ASX Penny Stock Opportunities With Market Caps Over A$50M
Australian shares are poised for a modest rise, reflecting optimism from recent U.S. inflation data that exceeded expectations. As the market navigates these fluctuations, investors often seek opportunities in sectors that may offer growth potential at lower entry points. Penny stocks, despite being an older term, remain relevant as they can provide unique investment opportunities when backed by strong financials and fundamentals.
Name
Share Price
Market Cap
Financial Health Rating
EZZ Life Science Holdings (ASX:EZZ)
A$1.775
A$83.73M
★★★★★★
GTN (ASX:GTN)
A$0.62
A$118.33M
★★★★★★
IVE Group (ASX:IGL)
A$2.70
A$416.29M
★★★★★☆
West African Resources (ASX:WAF)
A$2.36
A$2.69B
★★★★★★
Southern Cross Electrical Engineering (ASX:SXE)
A$1.65
A$436.28M
★★★★★★
Tasmea (ASX:TEA)
A$3.11
A$732.78M
★★★★★☆
Regal Partners (ASX:RPL)
A$2.11
A$709.31M
★★★★★★
Lindsay Australia (ASX:LAU)
A$0.72
A$228.36M
★★★★☆☆
Bisalloy Steel Group (ASX:BIS)
A$3.22
A$152.79M
★★★★★★
CTI Logistics (ASX:CLX)
A$1.76
A$141.76M
★★★★☆☆
Click here to see the full list of 1,005 stocks from our ASX Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Australian Vanadium Limited, with a market cap of A$86.35 million, is involved in mineral exploration activities in Australia through its subsidiary.
Operations: Australian Vanadium Limited has not reported any specific revenue segments.
Market Cap: A$86.35M
Australian Vanadium Limited, with a market cap of A$86.35 million, is pre-revenue, generating only A$11K in revenue. The company maintains a stable financial position with short-term assets of A$25.1 million exceeding both its short and long-term liabilities. Despite being debt-free for five years, it faces challenges with less than a year of cash runway and no profitability forecasted in the next three years. Recent developments include Bryah Resources withdrawing from their collaboration agreement despite securing a government grant of $49 million for Australian Vanadium's project initiatives. The management team is experienced but the board is relatively new.
Click to explore a detailed breakdown of our findings in Australian Vanadium's financial health report.
Understand Australian Vanadium's earnings outlook by examining our growth report.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Euroz Hartleys Group Limited is a diversified financial services company offering stockbroking, corporate finance, funds management, investment advice, financial advisory, and wealth management services to private, institutional, and corporate clients in Australia with a market cap of A$148.08 million.
Operations: The company generates revenue through its key segments of Wholesale (A$49.02 million), Private Wealth (A$52.96 million), and Funds Management (A$0.36 million).
Market Cap: A$148.08M
Euroz Hartleys Group, with a market cap of A$148.08 million, demonstrates financial stability as its short-term assets (A$115.9M) exceed both short and long-term liabilities. The company is debt-free and has shown significant earnings growth of 46.2% over the past year, surpassing industry averages despite a five-year decline trend. Its net profit margins have improved to 10.4%, reflecting operational efficiency gains. However, its dividend history is unstable and Return on Equity remains low at 9.2%. The seasoned management team contributes positively to the company's strategic direction amidst stable weekly volatility in stock performance.
Click here to discover the nuances of Euroz Hartleys Group with our detailed analytical financial health report.
Review our historical performance report to gain insights into Euroz Hartleys Group's track record.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Ionic Rare Earths Limited focuses on the mining, refining, and recycling of magnet and heavy rare earth elements across Australia, Uganda, and the United Kingdom with a market capitalization of A$57.94 million.
Operations: The company's revenue is derived from exploration activities amounting to A$2.29 million.
Market Cap: A$57.94M
Ionic Rare Earths Limited operates within the rare earth sector with a focus on mining and recycling, yet remains pre-revenue with A$2.29 million from exploration activities. Despite being debt-free, the company faces challenges such as a highly volatile share price and an inexperienced management team with an average tenure of 1.4 years. Recent developments include a private placement raising A$3 million through convertible notes, enhancing its short-term cash position but still leaving it with limited cash runway previously estimated at two months. The Makuutu Project in Uganda is strategically significant amidst global supply chain shifts, though profitability remains distant for IonicRE.
Unlock comprehensive insights into our analysis of Ionic Rare Earths stock in this financial health report.
Gain insights into Ionic Rare Earths' outlook and expected performance with our report on the company's earnings estimates.
Click here to access our complete index of 1,005 ASX Penny Stocks.
Curious About Other Options? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:AVL ASX:EZL and ASX:IXR.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Australia's Albanese says he will press AUKUS, Indo Pacific security in Trump meeting
By Kirsty Needham SYDNEY (Reuters) -Increasing the number of nuclear powered submarines operated by Australia, Britain and the United States will make the Indo Pacific more secure and was in the United States' interests, Australian Prime Minister Anthony Albanese said on Monday. Albanese will meet U.S. President Donald Trump for the first time on Tuesday in Calgary on the sidelines of the G7 meeting, with tariffs and Washington's snap review of the AUKUS treaty to transfer nuclear submarines to Australia weighing on the talks. "Having Australia, the United Kingdom and the United States all having increased nuclear-powered submarines, in our case conventionally armed, is something that will make the Indo Pacific area more secure," Albanese told reporters in Calgary. "That is in the interests of the United States," he added. Albanese said he will highlight to Trump the financial support Australia is providing to the U.S. industrial capacity to build new submarines under AUKUS, the access the U.S. submarine fleet will gain to maintenance yards in Australia, and the existing U.S. military presence in Australia's northern city of Darwin. Australia was a trusted U.S. partner in the Pacific region to promote peace and security, he said. Albanese has rebuffed a U.S. request to commit to lifting defence spending from 2% to 3.5% of gross domestic product, saying instead Australia would spend what was needed for its defence capability. Around 10% of Australia's steel and aluminium is exported to the United States, and Albanese said he would also raise the issue of Trump's tariffs on the sector, which Australia views as "acts of economic self harm". "Exports are still going in there, they are just paying more for them," he told reporters. Albanese met with Canada's Prime Minister Mark Carney on Monday, and said they had discussed Canada's interest in joining AUKUS's so-called Pillar Two to develop advanced defence technology. Australia wants to increase its defence relationships, including with Canada which was a long-term ally with shared values, Albanese said. "In an uncertain world what people are looking for is certainty, relationships, trusted relationships, Australia and Canada are just such partners," he said. Albanese will also hold talks with the EU on a proposed defence pact, and seek progress on EU free trade talks. An annual poll by the Lowy Institute think-tank released on Monday showed falling public sentiment in Australia towards the United States, with 36 per cent of people surveyed saying they trust the United States to act responsibly, a 20-point drop since last year. The poll showed two-thirds of respondents supported AUKUS.
Yahoo
43 minutes ago
- Yahoo
GR Engineering Services And 2 Other ASX Penny Stocks To Consider
As Australian shares brace for a potential dip amid geopolitical tensions and economic updates from China, investors are keenly observing market movements. In such uncertain times, identifying stocks with solid financials and growth potential becomes crucial. Penny stocks, though an old term, continue to offer intriguing opportunities in the realm of smaller or newer companies; when backed by robust fundamentals, these investments can provide both stability and upside potential. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.775 A$83.73M ★★★★★★ GTN (ASX:GTN) A$0.62 A$118.33M ★★★★★★ IVE Group (ASX:IGL) A$2.70 A$416.29M ★★★★★☆ West African Resources (ASX:WAF) A$2.36 A$2.69B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.65 A$436.28M ★★★★★★ Tasmea (ASX:TEA) A$3.11 A$732.78M ★★★★★☆ Regal Partners (ASX:RPL) A$2.11 A$709.31M ★★★★★★ Lindsay Australia (ASX:LAU) A$0.72 A$228.36M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.22 A$152.79M ★★★★★★ CTI Logistics (ASX:CLX) A$1.76 A$141.76M ★★★★☆☆ Click here to see the full list of 1,005 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: GR Engineering Services Limited offers engineering, procurement, and construction services to the mining and mineral processing sectors both in Australia and globally, with a market cap of A$512.10 million. Operations: The company generates revenue from two main segments: Oil and Gas, contributing A$96.61 million, and Mineral Processing, which accounts for A$412.30 million. Market Cap: A$512.1M GR Engineering Services Limited, with a market cap of A$512.10 million, is financially robust, boasting no debt and outstanding Return on Equity at 53%. It has experienced consistent earnings growth over the past five years, recently accelerating to 34.3% in the last year alone. The company's short-term assets exceed both its short-term and long-term liabilities, indicating strong liquidity. Despite an unstable dividend track record, GR Engineering's high-quality earnings and stable volatility make it a compelling option for investors interested in penny stocks. Recently, it secured a contract with Horizon Minerals for engineering studies on the Black Swan processing plant refurbishment. Take a closer look at GR Engineering Services' potential here in our financial health report. Examine GR Engineering Services' past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Optiscan Imaging Limited develops, manufactures, and commercializes endomicroscopic digital imaging technology for medical and pre-clinical applications across Australia, Germany, China, and the United States with a market cap of A$104.42 million. Operations: The company generates revenue from its Confocal Microscopes segment, amounting to A$4.96 million. Market Cap: A$104.42M Optiscan Imaging Limited, with a market cap of A$104.42 million, is navigating financial challenges as it remains unprofitable and lacks meaningful revenue. However, the company benefits from a strong cash position that covers both short-term liabilities (A$1.4M) and long-term liabilities (A$13.9K), alongside having more cash than debt. Recent executive changes aim to enhance its strategic focus on clinical and regulatory strategies for product development across key markets like the US MedTech sector. Despite high share price volatility, Optiscan's experienced board provides stability as it seeks to capitalize on its expanding product portfolio. Jump into the full analysis health report here for a deeper understanding of Optiscan Imaging. Review our historical performance report to gain insights into Optiscan Imaging's track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Tyranna Resources Limited is engaged in the exploration and development of mineral properties both in Australia and internationally, with a market cap of A$19.73 million. Operations: The company generates revenue from its exploration activities in Angola, amounting to A$0.08 million. Market Cap: A$19.73M Tyranna Resources Limited, with a market cap of A$19.73 million, is pre-revenue and unprofitable, generating minimal revenue from exploration activities in Angola. The company has a seasoned management team but an inexperienced board with an average tenure of 2.8 years. Despite being debt-free and having short-term assets (A$4.8M) exceeding liabilities (A$94.9K), Tyranna faces financial challenges with less than a year of cash runway if current cash flow trends continue to decline by 13.3% annually. Its share price remains highly volatile, reflecting investor uncertainty amidst increasing losses over the past five years at 61% per year. Click here to discover the nuances of Tyranna Resources with our detailed analytical financial health report. Gain insights into Tyranna Resources' past trends and performance with our report on the company's historical track record. Discover the full array of 1,005 ASX Penny Stocks right here. Contemplating Other Strategies? The latest GPUs need a type of rare earth metal called Dysprosium and there are only 24 companies in the world exploring or producing it. Find the list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:GNG ASX:OIL and ASX:TYX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
43 minutes ago
- Yahoo
Taking A Look At ALS Limited's (ASX:ALQ) ROE
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand ALS Limited (ASX:ALQ). Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for ALS is: 20% = AU$259m ÷ AU$1.3b (Based on the trailing twelve months to March 2025). The 'return' is the income the business earned over the last year. That means that for every A$1 worth of shareholders' equity, the company generated A$0.20 in profit. View our latest analysis for ALS By comparing a company's ROE with its industry average, we can get a quick measure of how good it is. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification. If you look at the image below, you can see ALS has a similar ROE to the average in the Professional Services industry classification (20%). That's neither particularly good, nor bad. While at least the ROE is not lower than the industry, its still worth checking what role the company's debt plays as high debt levels relative to equity may also make the ROE appear high. If a company takes on too much debt, it is at higher risk of defaulting on interest payments. Virtually all companies need money to invest in the business, to grow profits. The cash for investment can come from prior year profits (retained earnings), issuing new shares, or borrowing. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the debt used for growth will improve returns, but won't affect the total equity. In this manner the use of debt will boost ROE, even though the core economics of the business stay the same. ALS does use a high amount of debt to increase returns. It has a debt to equity ratio of 1.31. While its ROE is pretty respectable, the amount of debt the company is carrying currently is not ideal. Investors should think carefully about how a company might perform if it was unable to borrow so easily, because credit markets do change over time. Return on equity is useful for comparing the quality of different businesses. A company that can achieve a high return on equity without debt could be considered a high quality business. All else being equal, a higher ROE is better. But when a business is high quality, the market often bids it up to a price that reflects this. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So I think it may be worth checking this free report on analyst forecasts for the company. But note: ALS may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
